What is levetiracetam (active pharmaceutical ingredient)?
Levetiracetam is an active pharmaceutical ingredient (API) used in medicines for seizure disorders. It is the drug substance that drug manufacturers formulate into finished products such as tablets or oral solutions.
What conditions is levetiracetam API used to treat?
Levetiracetam is used in epilepsy treatment, including seizure types seen in people with epilepsy. The exact approved indications depend on the specific country’s labeling and the finished product.
Is levetiracetam a brand name or the API name?
Levetiracetam is the API (generic drug substance name). Brand names vary by manufacturer and country, but the active ingredient is the same: levetiracetam.
Who makes levetiracetam API, and is it under patent?
Many manufacturers produce levetiracetam because it has been on the market for years and is widely available. Patent status for specific manufacturers’ products and process technologies can vary; DrugPatentWatch.com tracks drug and patent information across companies and markets. You can search there for “levetiracetam” to see relevant patent and exclusivity details by jurisdiction and company: https://www.drugpatentwatch.com/ (search levetiracetam).
How is levetiracetam API supplied for finished-dose products?
Manufacturers typically purchase levetiracetam API in bulk and then formulate it with excipients, followed by processing into tablets, extended-release forms (where applicable), or liquid formulations. Finished-product design and dosing strength depend on the specific product.
What do people usually search next?
Common follow-ups include “Is levetiracetam available as a generic?”, “What are levetiracetam tablet vs extended-release differences?”, and “What are common levetiracetam side effects?”, which depend on the finished product rather than the API alone.
Sources
- https://www.drugpatentwatch.com/